| P2093 | author name string | Alan O Perantoni | |
| | Genbin Shi | |
| | Scott Boyle | |
| | Yu Shyr | |
| | Harold N Lovvorn | |
| | Mark de Caestecker | |
| | Marcia L Wills | |
| P2860 | cites work | The MSG1 non-DNA-binding transactivator binds to the p300/CBP coactivators, enhancing their functional link to the Smad transcription factors | Q22253348 |
| | Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein | Q24291743 |
| | Cited1 is a bifunctional transcriptional cofactor that regulates early nephronic patterning | Q24300488 |
| | msg1, a novel melanocyte-specific gene, encodes a nuclear protein and is associated with pigmentation | Q24318394 |
| | MSG1 and its related protein MRG1 share a transcription activating domain | Q24321610 |
| | Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator | Q24324502 |
| | Mutation and cancer: statistical study of retinoblastoma | Q24618185 |
| | TGF-beta signalling from cell membrane to nucleus through SMAD proteins | Q28131770 |
| | The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain | Q28142707 |
| | Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2 | Q28283345 |
| | A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye | Q28508005 |
| | Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4 | Q28508296 |
| | TGFbeta superfamily signals are required for morphogenesis of the kidney mesenchyme progenitor population | Q28513547 |
| | TGF beta 2, LIF and FGF2 cooperate to induce nephrogenesis | Q28580797 |
| | Mutation and cancer: a model for Wilms' tumor of the kidney | Q34207334 |
| | Epidemiology of Wilms tumor | Q34305834 |
| | Interaction between FGF and BMP signaling pathways regulates development of metanephric mesenchyme | Q35199256 |
| | Retroviral delivery of peptide modulators of cellular functions | Q38309613 |
| | Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta. | Q40481651 |
| | The management and biological behavior of Wilms tumor. | Q40596088 |
| | The impact of tumor histology on treatment and prognosis of pediatric neoplasms. | Q40689811 |
| | Serum hyaluronan and its association with unfavorable histology and aggressiveness of heterotransplanted Wilms' tumor | Q40864996 |
| | Wilms tumor | Q40939264 |
| | Epidemiologic features of Wilms tumor | Q40964142 |
| | Histopathology of childhood renal tumors | Q40964148 |
| | Histological analysis of aggressiveness and responsiveness in Wilms' tumor | Q41127718 |
| | New developments in the pathology of Wilms tumor | Q41421689 |
| | Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells. | Q45869399 |
| | Regulation of expression of MSG1 melanocyte-specific nuclear protein in human melanocytes and melanoma cells | Q47769214 |
| | Msg1 and Mrg1, founding members of a gene family, show distinct patterns of gene expression during mouse embryogenesis. | Q48038317 |
| | Transforming growth factor-beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis. | Q52049617 |
| | BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning | Q71817916 |
| | Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells | Q74688277 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1 | Q21116830 |
| | positive regulation of mesenchymal stem cell proliferation | Q21119363 |
| P304 | page(s) | 474-81 | |
| P577 | publication date | 2007-03-01 | |
| P1433 | published in | Journal of Pediatric Surgery | Q15761821 |
| P1476 | title | Wilms' tumorigenesis is altered by misexpression of the transcriptional co-activator, CITED1 | |
| P478 | volume | 42 | |